Amantadine: Effective Antiviral and Neurological Symptom Management
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.91 | $54.44 (0%) | 🛒 Add to cart |
| 90 | $0.83 | $81.67 $74.61 (9%) | 🛒 Add to cart |
| 120 | $0.79 | $108.89 $94.77 (13%) | 🛒 Add to cart |
| 180 | $0.74 | $163.33 $133.09 (19%) | 🛒 Add to cart |
| 270 | $0.72 | $245.00 $194.59 (21%) | 🛒 Add to cart |
| 360 | $0.70
Best per pill | $326.67 $251.05 (23%) | 🛒 Add to cart |
Synonyms | |||
Amantadine is a versatile antiviral and neurological agent, primarily indicated for the prophylaxis and treatment of influenza A virus infections and the management of Parkinson’s disease symptoms. It functions through dual mechanisms: inhibiting viral replication and modulating dopaminergic neurotransmission, offering a unique therapeutic profile. Its established efficacy and well-documented safety make it a valuable option in both infectious disease and movement disorder protocols.
Features
- Chemical name: 1-adamantanamine hydrochloride
- Molecular formula: C₁₀H₁₇N·HCl
- Mechanism: Blocks viral M2 ion channel and enhances dopamine release
- Administration: Oral capsule or syrup formulation
- Bioavailability: Approximately 90% following oral administration
- Half-life: 12–18 hours in adults with normal renal function
- Excretion: Primarily renal, unchanged
Benefits
- Reduces duration and severity of influenza A symptoms when administered early
- Provides symptomatic relief in Parkinson’s disease, particularly for rigidity and bradykinesia
- May ameliorate drug-induced extrapyramidal symptoms in psychiatric patients
- Demonstrates neuroprotective properties in certain neurological conditions
- Offers convenient once or twice-daily dosing for improved adherence
- Serves as adjunctive therapy to optimize levodopa response fluctuations
Common use
Amantadine is commonly prescribed for prophylaxis and treatment of influenza A virus infections, particularly in high-risk populations. In neurology, it is utilized as monotherapy in early Parkinson’s disease or as adjunctive treatment with levodopa in more advanced stages. Off-label applications include management of fatigue in multiple sclerosis and treatment of certain drug-induced movement disorders.
Dosage and direction
For influenza prophylaxis: 200 mg once daily or 100 mg twice daily in adults. For influenza treatment: 200 mg initially, then 100 mg daily or 100 mg twice daily. For Parkinson’s disease: Initial dose of 100 mg daily, increasing to 100 mg twice daily after one week. Maximum daily dose should not exceed 400 mg in divided doses. Renal impairment requires dosage adjustment based on creatinine clearance. Administration with food may minimize gastrointestinal discomfort.
Precautions
Monitor renal function regularly during therapy. Use caution in patients with history of seizures or psychiatric disorders. Elderly patients may require reduced dosing due to decreased renal function. Gradual titration is recommended to minimize side effects. Patients should avoid abrupt discontinuation to prevent rebound Parkinsonian symptoms. Caution advised when operating machinery due to potential dizziness or blurred vision.
Contraindications
Hypersensitivity to amantadine or any component of the formulation. Severe renal impairment (creatinine clearance <15 mL/min). Pregnancy unless potential benefit justifies potential risk. Breastfeeding is not recommended due to secretion in human milk. History of angle-closure glaucoma. Concurrent use with live attenuated influenza vaccine.
Possible side effect
Common reactions include nausea, dizziness, insomnia, and peripheral edema. Less frequently observed are orthostatic hypotension, livedo reticularis, and anticholinergic effects. Neuropsychiatric effects such as anxiety, depression, or hallucinations may occur, particularly in elderly patients. Rare but serious side effects include suicidal ideation, seizures, and neuroleptic malignant syndrome upon withdrawal.
Drug interaction
Potentiates anticholinergic effects when combined with other anticholinergic agents. May enhance CNS stimulation when used with sympathomimetics. Concurrent use with alcohol may increase CNS depression. Triamterene and hydrochlorothiazide may decrease amantadine clearance. May reduce efficacy of live attenuated influenza vaccine. Caution required with drugs affecting renal function.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed administration. Maintain regular dosing schedule to ensure consistent therapeutic levels. Consult healthcare provider if multiple doses are missed for guidance on resumption protocol.
Overdose
Symptoms may include severe nausea, vomiting, agitation, hallucinations, and cardiac arrhythmias. Management involves gastric lavage if presented early, activated charcoal, and supportive care. Acidification of urine may enhance elimination. Hemodialysis may be effective in severe cases. Monitor cardiac function and neurological status closely. Specific antidote is not available.
Storage
Store at controlled room temperature (20–25°C). Protect from light and moisture. Keep container tightly closed. Do not freeze liquid formulation. Keep out of reach of children and pets. Discard any unused medication after expiration date. Do not transfer capsules or syrup to other containers unless specifically instructed.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any medication regimen. Individual response to therapy may vary. Proper diagnosis and supervision are essential for safe and effective use. Not all possible uses, precautions, or interactions are listed here.
Reviews
Clinical studies demonstrate amantadine’s efficacy in reducing influenza A symptom duration by 1–2 days when initiated within 48 hours of onset. In Parkinson’s disease, trials show significant improvement in Unified Parkinson’s Disease Rating Scale scores. Patient reports frequently note improvement in motor symptoms and quality of life, though some report tolerance development over time. Medical professionals value its dual mechanisms but emphasize careful patient selection and monitoring.